The Arenaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype Pathogens

Author:

Hastie Kathryn M1,Melnik Lilia I2,Cross Robert W3,Klitting Raphaëlle M45,Andersen Kristian G45,Saphire Erica Ollmann16,Garry Robert F27

Affiliation:

1. Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology , La Jolla, California , USA

2. Department of Microbiology and Immunology, Tulane University School of Medicine , New Orleans, Louisiana , USA

3. Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston National Laboratory , Galveston, Texas , USA

4. Department of Immunology and Microbiology, The Scripps Research Institute , La Jolla, California , USA

5. Scripps Research Translational Institute , La Jolla, California , USA

6. Department of Medicine, University of California San Diego , La Jolla, California , USA

7. Zalgen Labs LLC , Frederick, Maryland , USA

Abstract

Abstract Lassa virus (LASV), Junin virus (JUNV), and several other members of the Arenaviridae family are capable of zoonotic transfer to humans and induction of severe viral hemorrhagic fevers. Despite the importance of arenaviruses as potential pandemic pathogens, numerous gaps exist in scientific knowledge pertaining to this diverse family, including gaps in understanding replication, immunosuppression, receptor usage, and elicitation of neutralizing antibody responses, that in turn complicates development of medical countermeasures. A further challenge to the development of medical countermeasures for arenaviruses is the requirement for use of animal models at high levels of biocontainment, where each model has distinct advantages and limitations depending on, availability of space, animals species-specific reagents, and most importantly the ability of the model to faithfully recapitulate human disease. Designation of LASV and JUNV as prototype pathogens can facilitate progress in addressing the public health challenges posed by members of this important virus family.

Funder

National Institutes of Health

Coalition for Epidemic Preparedness Innovation

Wellcome Trust Foundation

Gilead Sciences

European and Developing Countries Clinical Trials Partnership Programme

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3